Financhill
Buy
57

BOKF Quote, Financials, Valuation and Earnings

Last price:
$103.86
Seasonality move :
4.4%
Day range:
$101.08 - $103.97
52-week range:
$85.08 - $121.58
Dividend yield:
2.18%
P/E ratio:
11.94x
P/S ratio:
3.33x
P/B ratio:
1.16x
Volume:
189.5K
Avg. volume:
221.3K
1-year change:
-0.29%
Market cap:
$6.7B
Revenue:
$1.9B
EPS (TTM):
$8.70
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $1.9B $1.8B $1.8B $2B $1.9B
Revenue Growth (YoY) 8.06% -6.39% 2.9% 8.59% -1.96%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $738M $727.6M $715.3M $873M $881.1M
Other Inc / (Exp) $26M $23.7M -$14.1M -$48M -$50.1M
Operating Expenses $758.5M $745.9M $731M $886.8M $892.8M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $563.9M $796.1M $660.2M $683.2M $666.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $128.8M $179.8M $139.9M $152.1M $143.1M
Net Income to Company $435.1M $616.3M $520.3M $531.1M $523.6M
 
Minority Interest in Earnings -$41K $1.8M -$20K -$387K $16K
Net Income to Common Excl Extra Items $435M $618.1M $520.3M $530.7M $523.6M
 
Basic EPS (Cont. Ops) $6.19 $8.95 $7.68 $8.02 $8.14
Diluted EPS (Cont. Ops) $6.19 $8.95 $7.68 $8.02 $8.14
Weighted Average Basic Share $69.8M $68.6M $67.2M $65.7M $63.7M
Weighted Average Diluted Share $69.8M $68.6M $67.2M $65.7M $63.7M
 
EBITDA -- -- -- -- --
EBIT $724.4M $858M $840.9M $1.8B $2.1B
 
Revenue (Reported) $1.9B $1.8B $1.8B $2B $1.9B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $724.4M $858M $840.9M $1.8B $2.1B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $433.4M $348.4M $524.4M $448.9M $495.3M
Revenue Growth (YoY) -1.92% -19.62% 50.53% -14.4% 10.34%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $183.2M $173.7M $198M $225.8M $230.1M
Other Inc / (Exp) $4.8M -$8.1M -$10.4M -$43.1M $2.7M
Operating Expenses $184M $177.7M $201.4M $228.8M $232.8M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $186.7M $78.6M $208.4M $106.9M $154.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $42.4M $16.2M $45.9M $23.2M $35M
Net Income to Company $144.3M $62.5M $162.5M $83.7M $119.8M
 
Minority Interest in Earnings $1.8M $36K -$128K $9K $6K
Net Income to Common Excl Extra Items $146.1M $62.5M $162.4M $83.7M $119.8M
 
Basic EPS (Cont. Ops) $2.10 $0.91 $2.43 $1.29 $1.86
Diluted EPS (Cont. Ops) $2.10 $0.91 $2.43 $1.29 $1.86
Weighted Average Basic Share $69.1M $67.8M $66.3M $64.3M $63.5M
Weighted Average Diluted Share $69.1M $67.8M $66.3M $64.3M $63.5M
 
EBITDA -- -- -- -- --
EBIT $204.5M $93.3M $372.8M $458.5M $457.1M
 
Revenue (Reported) $433.4M $348.4M $524.4M $448.9M $495.3M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $204.5M $93.3M $372.8M $458.5M $457.1M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.8B $1.7B $2B $1.9B $2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $749.6M $718M $735.7M $900.8M $885.4M
Other Inc / (Exp) -$53.4M $10.8M -$16.3M -$80.7M -$4.3M
Operating Expenses $762.8M $735.5M $750.9M $914.2M $896.7M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $671.3M $688.1M $789.9M $581.7M $714.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $153.9M $153.6M $169.6M $129.4M $154.9M
Net Income to Company $517.4M $534.5M $620.3M $452.3M $559.6M
 
Minority Interest in Earnings $1.6M $80K -$184K -$250K $13K
Net Income to Common Excl Extra Items $519M $534.5M $620.2M $452.1M $559.6M
 
Basic EPS (Cont. Ops) $7.42 $7.76 $9.22 $6.86 $8.70
Diluted EPS (Cont. Ops) $7.42 $7.76 $9.22 $6.86 $8.70
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- --
EBIT $762.1M $746.8M $1.1B $1.8B $2.1B
 
Revenue (Reported) $1.8B $1.7B $2B $1.9B $2B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $762.1M $746.8M $1.1B $1.8B $2.1B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $433.4M $348.4M $524.4M $448.9M $495.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $183.2M $173.7M $198M $225.8M $230.1M
Other Inc / (Exp) $4.8M -$8.1M -$10.4M -$43.1M $2.7M
Operating Expenses $184M $177.7M $201.4M $228.8M $232.8M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $186.7M $78.6M $208.4M $106.9M $154.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $42.4M $16.2M $45.9M $23.2M $35M
Net Income to Company $144.3M $62.5M $162.5M $83.7M $119.8M
 
Minority Interest in Earnings $1.8M $36K -$128K $9K $6K
Net Income to Common Excl Extra Items $146.1M $62.5M $162.4M $83.7M $119.8M
 
Basic EPS (Cont. Ops) $2.10 $0.91 $2.43 $1.29 $1.86
Diluted EPS (Cont. Ops) $2.10 $0.91 $2.43 $1.29 $1.86
Weighted Average Basic Share $69.1M $67.8M $66.3M $64.3M $63.5M
Weighted Average Diluted Share $69.1M $67.8M $66.3M $64.3M $63.5M
 
EBITDA -- -- -- -- --
EBIT $204.5M $93.3M $372.8M $458.5M $457.1M
 
Revenue (Reported) $433.4M $348.4M $524.4M $448.9M $495.3M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $204.5M $93.3M $372.8M $458.5M $457.1M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $1.2B $2.8B $1.4B $1.3B $1.4B
Short Term Investments $13.1B $13.2B $11.5B $12.3B $12.9B
Accounts Receivable, Net $245.9M $223M $273.8M $317.9M $281.1M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $15.5B $17.4B $14.4B $14.8B $14.8B
 
Property Plant And Equipment $551.3M $574.1M $565.2M $622.2M $634.5M
Long-Term Investments $18B $22.5B $18.5B $19.7B $19.8B
Goodwill $1B $1B $1B $1B $1B
Other Intangibles $214.6M $255M $353.7M $353.9M $384.9M
Other Long-Term Assets -- -- -- -- --
Total Assets $46.7B $50.2B $47.8B $49.8B $49.7B
 
Accounts Payable $323.7M $273M $296.9M $339M $352.3M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.9B $2.8B $2.7B $1.7B $2.1B
 
Long-Term Debt $503.5M $160.6M $4.9B $7.8B $3.1B
Capital Leases -- -- -- -- --
Total Liabilities $41.4B $44.9B $43.1B $44.7B $44.1B
 
Common Stock $5K $5K $5K $5K $5K
Other Common Equity Adj $335.9M $72.4M -$837M -$599.1M -$503M
Common Equity $5.3B $5.4B $4.7B $5.1B $5.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $25.3M $4.6M $4.7M $3M $2.6M
Total Equity $5.3B $5.4B $4.7B $5.1B $5.6B
 
Total Liabilities and Equity $46.7B $50.2B $47.8B $49.8B $49.7B
Cash and Short Terms $14.2B $16B $12.9B $13.6B $14.3B
Total Debt $2.1B $160.6M $4.9B $7.8B $3.1B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $1.4B $1.4B $1.4B $1.2B $1.4B
Short Term Investments $13.4B $12.9B $11.9B $12.7B $1.7B
Accounts Receivable, Net $250.9M $238.7M $265.7M $308.7M $261.7M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $16.5B $17.6B $14.3B $14.5B $3.9B
 
Property Plant And Equipment $555.5M $574.8M $623.1M $628.1M $636.1M
Long-Term Investments $18.7B $18B $16.7B $20.3B $9.5B
Goodwill $1B $1B $1B $1B $1B
Other Intangibles $243.5M $297.3M $372.5M $376.2M $386.2M
Other Long-Term Assets -- -- -- -- --
Total Assets $47.4B $46.8B $45.5B $50.2B $50.5B
 
Accounts Payable $290.3M $238M $268.4M $318.6M $291.2M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $2.9B $1.4B $2.1B $1.9B $2.5B
 
Long-Term Debt $307.9M $161.2M $4.9B $6.8B $3.3B
Capital Leases -- -- -- -- --
Total Liabilities $42.2B $42B $40.6B $45B $44.7B
 
Common Stock $5K $5K $5K $5K $5K
Other Common Equity Adj $221.4M -$417.8M -$728.6M -$610.1M -$362.3M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $22.9M $3.9M $3.2M $2.9M $2.6M
Total Equity $5.3B $4.9B $4.9B $5.1B $5.8B
 
Total Liabilities and Equity $47.4B $46.8B $45.5B $50.2B $50.5B
Cash and Short Terms $14.8B $14.3B $13.3B $13.8B $3.1B
Total Debt $2B $161.2M $4.9B $6.8B $3.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $435.1M $616.3M $520.3M $531.1M $523.6M
Depreciation & Amoritzation $99M $102.5M $107.6M $109.9M $105.3M
Stock-Based Compensation $16.4M $9.8M $11.6M $16.4M $22.9M
Change in Accounts Receivable $945.1M $39.2M -$34.3M -$316.8M $321.9M
Change in Inventories -- -- -- -- --
Cash From Operations -$416.3M -$3.7B $5.1B $66.2M $1.4B
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- $32.6M --
Cash From Investing -$2.5B $2.6B -$4.6B -$1.8B -$477.2M
 
Dividends Paid (Ex Special Dividend) -$144.4M -$144.1M -$143.8M -$143.4M -$143M
Special Dividend Paid
Long-Term Debt Issued -- -- $4.6B $1.8B --
Long-Term Debt Repaid -$5.1B -$1.4B -- -- --
Repurchase of Common Stock -$80.8M -$122.8M -$159.8M -$181.8M -$93.6M
Other Financing Activities -$409.6M -$665.3M $500.4M $655.2M -$274.8M
Cash From Financing $2.8B $2.7B -$2B $1.7B -$866.8M
 
Beginning Cash (CF) $1.3B $1.2B $2.8B $1.4B $1.3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$78.2M $1.7B -$1.4B -$53.5M $86.4M
Ending Cash (CF) $1.2B $2.8B $1.4B $1.3B $1.4B
 
Levered Free Cash Flow -$416.3M -$3.7B $5.1B $66.2M $1.4B
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Net Income to Stockholders $167.1M $132.9M $151.6M $163.7M --
Depreciation & Amoritzation $25.3M $26.9M $29.7M $25.7M --
Stock-Based Compensation $1.4M $10K $4.4M $5.5M --
Change in Accounts Receivable $44.6M $150.6M -$93.5M -$20.6M --
Change in Inventories -- -- -- -- --
Cash From Operations -$268.9M $2.5B -$3B $463.5M --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing $1B -$471.5M -$656M -$522.3M --
 
Dividends Paid (Ex Special Dividend) -$35.8M -$35.9M -$35.8M -$35.4M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$43.8M -$24.4M -$22.8M -$38.1M --
Other Financing Activities -$153.1M -$93.3M $222.2M -$154.8M --
Cash From Financing -$891.8M -$1.4B $3.8B -$20.8M --
 
Beginning Cash (CF) $1.4B $1.4B $1.4B $1.2B --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$159.7M $669.6M $83.3M -$79.6M --
Ending Cash (CF) $1.3B $2B $1.4B $1.1B --
 
Levered Free Cash Flow -$268.9M $2.5B -$3B $463.5M --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $517.4M $534.5M $620.3M $452.3M $559.6M
Depreciation & Amoritzation $100.7M $103.6M $108.4M $109.4M $106.2M
Stock-Based Compensation $15.9M $9.9M $15.4M $14.2M $24.2M
Change in Accounts Receivable $2.1B -$65M $65.3M -$42.9M $41.3M
Change in Inventories -- -- -- -- --
Cash From Operations $1.1B $459.6M $3.7B -$2.2B $1.3B
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$563.5M $1.7B -$4B -$2.1B $554.4M
 
Dividends Paid (Ex Special Dividend) -$144.5M -$144.2M -$143.9M -$142.6M -$143.9M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$67.3M -$150.9M -$155.8M -$188.1M -$44.7M
Other Financing Activities -$577.9M -$1.9B $2.3B -$26.2M -$247.6M
Cash From Financing -$98.1M -$2.2B $355.3M $4.1B -$1.6B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $446.1M -$51.4M -$3.8M -$208.2M $260.9M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.1B $459.6M $3.7B -$2.2B $1.3B
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Net Income to Stockholders $311.4M $195.3M $314.1M $247.4M $119.8M
Depreciation & Amoritzation $50.2M $53M $56.6M $52.1M $27.3M
Stock-Based Compensation $4.1M $2.8M $11.1M $10.1M $5.9M
Change in Accounts Receivable $60.3M $62M -$82.5M $264.4M $4.3M
Change in Inventories -- -- -- -- --
Cash From Operations -$487.8M $6.4B -$559.8M $642.8M $20.3M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing $978.9M -$1.4B -$969.3M -$1.1B $434.7M
 
Dividends Paid (Ex Special Dividend) -$72M -$72.2M -$72.1M -$71M -$36.5M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$68.7M -$77.4M -$71.8M -$93.4M -$6.4M
Other Financing Activities -$243M -$1.4B $695.5M -$362.9M -$180.9M
Cash From Financing -$412.2M -$5.9B $1.6B $204.3M -$473M
 
Beginning Cash (CF) $2.6B $4.2B $2.8B $2.5B $1.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $78.9M -$800.1M $45.6M -$272.1M -$18M
Ending Cash (CF) $2.7B $3.4B $2.8B $2.2B $1.4B
 
Levered Free Cash Flow -$487.8M $6.4B -$559.8M $642.8M $20.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
71
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
68
MCRI alert for Jul 18

Monarch Casino & Resort [MCRI] is up 19.81% over the past day.

Sell
41
NEGG alert for Jul 18

Newegg Commerce [NEGG] is up 17.85% over the past day.

Buy
72
MNPR alert for Jul 18

Monopar Therapeutics [MNPR] is up 13.2% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock